Drug eluting stents (DES) – wire mesh tubes that prop open a previously blocked artery to the heart –have gone a long way toward reducing restenosis in cardiac patients after percutaneous coronary intervention. But they've also created a host of potential complications from impairing imaging to hindering surgical revascularization or positive remodeling (an increase in arterial area).